Charles F. Samelson, M.D.
Country not established
- Devices
- 1
What Charles F. Samelson, M.D. makes
Charles F. Samelson, M.D. manufactures the LINQUAL-ORAL TRAINING SPLINT, a device designed for oral training and rehabilitation, likely used in speech therapy or orthodontic treatment.
The LINQUAL-ORAL TRAINING SPLINT is classified under FDA’s 510(k) pathway, indicating it is a Class II medical device. The manufacturer is based in the United States.
Catalogue
DeviceDevice · Authorizations Verified Status Regime Registry Class
Linqual-Oral Training Splint Ref K813603
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Charles F. Samelson, M.D. have in the registry?
The registry currently lists 1 device for Charles F. Samelson, M.D.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Charles F. Samelson, M.D.'s devices?
Among its 1 most recently registered device, Charles F. Samelson, M.D. has devices listed in FDA 510(k) (1 device).
What are the newest devices from Charles F. Samelson, M.D. in the registry?
The most recently registered devices listed for Charles F. Samelson, M.D. include LINQUAL-ORAL TRAINING SPLINT.